These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25954565)

  • 1. Discovery of Intra-Abdominal Hemorrhage during Hernioplasty in a Patient Taking Rivaroxaban.
    Chow H; Ng MK
    Case Rep Surg; 2015; 2015():345716. PubMed ID: 25954565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis.
    Feng W; Wu K; Liu Z; Kong G; Deng Z; Chen S; Wu Y; Chen M; Liu S; Wang H
    Thromb Res; 2015 Dec; 136(6):1133-44. PubMed ID: 26498222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of switch-therapy modalities (enoxaparin to rivaroxaban/dabigatran) and enoxaparin monotherapy after hip and knee replacement.
    Özler T; Uluçay Ç; Önal A; Altıntaş F
    Acta Orthop Traumatol Turc; 2015; 49(3):255-9. PubMed ID: 26200403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis.
    Wu CT; Chen B; Wang JW; Yen SH; Huang CC
    J Orthop Surg Res; 2018 Jul; 13(1):173. PubMed ID: 29996862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study.
    Lazo-Langner A; Fleet JL; McArthur E; Garg AX
    J Thromb Haemost; 2014 Oct; 12(10):1626-35. PubMed ID: 25069387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study.
    Agnelli G; Gallus A; Goldhaber SZ; Haas S; Huisman MV; Hull RD; Kakkar AK; Misselwitz F; Schellong S;
    Circulation; 2007 Jul; 116(2):180-7. PubMed ID: 17576867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Ning GZ; Kan SL; Chen LX; Shangguan L; Feng SQ; Zhou Y
    Sci Rep; 2016 Mar; 6():23726. PubMed ID: 27020475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case-control study on three antithrombotic agents for the prevention of venous thromboembolism after unilateral total knee arthroplasty].
    Miao SG; Zhang XG; Lu JH; Yang Y; Lu N
    Zhongguo Gu Shang; 2015 Oct; 28(10):893-6. PubMed ID: 26727779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of rivaroxaban thromboprophylaxis after arthroplasty of the hip or knee: retrospective cohort study.
    Loganathan V; Hua A; Patel S; Gibbons C; Vizcaychipi MP
    Ann R Coll Surg Engl; 2016 Sep; 98(7):507-15. PubMed ID: 27580310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk of bleeding and haemorrhagic complication with rivaroxaban--periprocedural management of haemostasis].
    Koscielny J; Beyer-Westendorf J; von Heymann C; Braun J; Klamroth R; Lindhoff-Last E; Tiede A; Spannagl M
    Hamostaseologie; 2012; 32(4):287-93. PubMed ID: 23114797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis.
    Kim YT; Kang MW; Lee JK; Lee YM; Kim JI
    BMC Musculoskelet Disord; 2018 Jul; 19(1):227. PubMed ID: 30021575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical efficacy of rivaroxaban in prevention and treatment of postoperative deep vein thrombosis for severe traumatic brain injury].
    Zhang ZL; Liu WM; Zhang Y; Wang GH; Yan C; Wang HQ; Huang QB
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3558-3561. PubMed ID: 29275595
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute-onset severe gastrointestinal tract hemorrhage in a postoperative patient taking rivaroxaban after total hip arthroplasty: a case report.
    Boland M; Murphy M; Murphy M; McDermott E
    J Med Case Rep; 2012 May; 6():129. PubMed ID: 22584072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-analysis model for anticoagulant treatment in the hospital setting.
    Mody SH; Huynh L; Zhuo DY; Tran KN; Lefebvre P; Bookhart B
    J Med Econ; 2014 Jul; 17(7):492-8. PubMed ID: 24773068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of acute deep vein thrombosis with new oral anticoagulant rivaroxaban: the first experience].
    Schastlivtsev IV; Lobastov KV; Barinov VE; Boiarintsev VV
    Khirurgiia (Mosk); 2014; (6):61-6. PubMed ID: 25042194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban Related Bilateral Adrenal Hemorrhage: A Rare Complications of Direct Oral Anticoagulants - A Case Reports.
    Alidoost M; Soomro R; Gubeladze A; Morabia A; Holland S; Asif A; Hossain MA
    Am J Case Rep; 2019 Nov; 20():1607-1611. PubMed ID: 31676747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative thoracic hemorrhage after right upper lobectomy with thoracic wall resection during rivaroxaban anticoagulant therapy for deep leg vein thrombosis: A case report.
    Kuwata T; Kanayama M; Hirai A; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Imanishi N; Kuroda K; Tanaka F
    Int J Surg Case Rep; 2017; 41():340-342. PubMed ID: 29145107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban.
    Kwong LM; Turpie AGG; Tamayo S; Peacock WF; Yuan Z; Sicignano N; Hopf KP; Patel MR
    Curr Med Res Opin; 2017 Sep; 33(9):1717-1723. PubMed ID: 28678604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
    Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
    N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.